Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer

Since BRCA mutations are only responsible for 10–20% of cases of breast cancer in patients with early-onset or a family history and since next-generation sequencing technology allows the simultaneous sequencing of a large number of target genes, testing for multiple cancer-predisposing genes is now...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Po-Han, Kuo, Wen-Hung, Huang, Ai-Chu, Lu, Yen-Shen, Lin, Ching-Hung, Kuo, Sung-Hsin, Wang, Ming-Yang, Liu, Chun-Yu, Cheng, Fiona Tsui-Fen, Yeh, Ming-Hsin, Li, Huei-Ying, Yang, Yu-Hsuan, Hsu, Yu-Hua, Fan, Sheng-Chih, Li, Long-Yuan, Yu, Sung-Liang, Chang, King-Jen, Chen, Pei-Lung, Ni, Yen-Hsuan, Huang, Chiun-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884994/
https://www.ncbi.nlm.nih.gov/pubmed/26824983
http://dx.doi.org/10.18632/oncotarget.7027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884994/
https://www.ncbi.nlm.nih.gov/pubmed/26824983
http://dx.doi.org/10.18632/oncotarget.7027

Ejemplares similares